Effective Management of Complex Central Nervous System (CNS) Studies

PPD mobilizes global therapeutic resources and integrated technologies to get our clients to market faster with expedited study start-up and data reporting. In a recent example, we completed a large and complex, pivotal Phase III study for a schizophrenia drug ahead of schedule and under budget. The study involved:

17 countries
13 languages
34 monitors
172 investigative sites
2,200 patients
1,420,000 CRF pages